Context Therapeutics (NasdaqCM:CNTX) FY Conference Transcript

Context Therapeutics (NasdaqCM:CNTX) FY Conference November 10, 2025 03:00 PM ET Speaker1All right. So welcome to this next session. My name is Paul Jiang. I'm one of the biotech analysts at Guggenheim, and I'm very pleased to welcome our next presenting company, Context Therapeutics. And with us today is Martin Lehr, CEO. Marty, thanks for joining us.Speaker0Thanks for having me.Speaker1Great. Before we get into the details, for those who are maybe newer to the story, could you provide a brief intro to Con ...